B-Cell Chronic Lymphocytic Leukemia - Pipeline Review, H2 2018

Industry: 

503 Views
Buy This Report

B-Cell Chronic Lymphocytic Leukemia - Pipeline Review, H2 2018, provides comprehensive information on the therapeutics under development for B-Cell Chronic Lymphocytic Leukemia (Oncology), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

  • 503 reads